Giuseppe Luigi Banna Selected Research

Giuseppe Luigi Banna Research Topics

Disease

33	Neoplasms (Cancer) 04/2024 - 01/2007
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 07/2011
16	Renal Cell Carcinoma (Grawitz Tumor) 12/2024 - 09/2020
10	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 09/2021
8	Carcinoma (Carcinomatosis) 11/2023 - 04/2015
6	Lung Neoplasms (Lung Cancer) 12/2023 - 09/2018
6	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2021
5	Disease Progression 01/2024 - 12/2008
5	Human Influenza (Influenza) 01/2020 - 10/2018
3	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2020
3	Malignant Mesothelioma 01/2022 - 01/2018
2	Mesothelioma 04/2024 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 01/2021
2	Circulating Neoplastic Cells 01/2022 - 09/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2020
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 05/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2021 - 11/2019
2	Glioblastoma (Glioblastoma Multiforme) 12/2008 - 02/2007
2	Hodgkin Disease (Hodgkin's Disease) 01/2004 - 01/2004
1	Pathologic Complete Response 04/2024
1	Sarcoma (Soft Tissue Sarcoma) 02/2024
1	Cognitive Dysfunction 01/2024
1	Exanthema (Rash) 10/2023
1	Febrile Neutropenia 01/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Vitelliform Macular Dystrophy 01/2022
1	Turcot syndrome 09/2021
1	Oncogene Addiction 07/2021
1	Microsatellite Instability 12/2020
1	Infections 01/2020
1	Carcinogenesis 01/2019
1	Dysbiosis 01/2019
1	Hepatitis 09/2018
1	HIV Infections (HIV Infection) 09/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2018

Drug/Important Bio-Agent (IBA)

28	Immune Checkpoint InhibitorsIBA 12/2024 - 09/2018
11	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2019
8	NivolumabIBA 04/2024 - 01/2021
5	Androgen Receptors (Androgen Receptor)IBA 10/2023 - 09/2021
5	pembrolizumabIBA 05/2022 - 01/2020
5	PlatinumIBA 11/2021 - 01/2019
4	Tyrosine Kinase InhibitorsIBA 12/2024 - 05/2016
4	LigandsIBA 04/2024 - 08/2020
4	cabozantinibIBA 10/2023 - 01/2022
3	B7-H1 AntigenIBA 01/2023 - 11/2020
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2016
3	SteroidsIBA 01/2021 - 01/2004
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 10/2018
2	enzalutamideIBA 04/2024 - 06/2023
2	Platinum Compounds (Compounds, Platinum)IBA 04/2024 - 01/2022
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 08/2020
2	pazopanib FDA Link 01/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2022 - 03/2009
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 07/2021
2	Cisplatin (Platino)FDA LinkGeneric 04/2015 - 07/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2015 - 06/2013
2	Temozolomide (Temodar)FDA LinkGeneric 12/2008 - 02/2007
1	DystrophinIBA 04/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2024
1	Anaplastic Lymphoma KinaseIBA 02/2024
1	Neuregulin-1 (Neuregulin 1)IBA 02/2024
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2024
1	tributyl phosphate (TBP)IBA 01/2024
1	SodiumIBA 11/2023
1	IpilimumabIBA 10/2023
1	apalutamideIBA 10/2023
1	AndrogensIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2023
1	abirateroneIBA 06/2023
1	Proteins (Proteins, Gene)FDA Link 04/2023
1	RadiopharmaceuticalsIBA 01/2023
1	AntigensIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	cabazitaxel FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	CrizotinibIBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Circulating Tumor DNAIBA 09/2021
1	Adenosine Monophosphate (AMP)IBA 12/2020
1	vinflunineIBA 12/2019
1	Immunoglobulin G (IgG)IBA 05/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	thiamine triphosphorate (TTP)IBA 09/2018

Therapy/Procedure

30	Immunotherapy 04/2024 - 09/2018
26	Drug Therapy (Chemotherapy) 04/2024 - 01/2004
21	Therapeutics 12/2024 - 01/2004
6	Radiotherapy 11/2020 - 01/2004
4	Castration 10/2023 - 01/2022
1	Terminal Care (Care, Terminal) 04/2024
1	Activities of Daily Living (ADL) 01/2024
1	Self Administration (Administration, Self) 12/2022
1	Nephrectomy 01/2022
1	Precision Medicine 09/2021
1	Retreatment 01/2021
1	Time-to-Treatment 11/2020
1	Cranial Irradiation 11/2019